Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake

Befikadu L. Wubishet, Wubshet H. Tesfaye, Md Nuruzzaman Khan, Jackson Thomas, Haitham Tuffaha, Tracy A. Comans, Paul Scuffham, Daniel A. Erku

Research output: Contribution to journalArticlepeer-review

Abstract

COVID-19 is one of the worst pandemics in recent human history, causing huge health, economic, and psychosocial damage. Since the pandemic hit, several unsubstantiated claims regarding exposure, transmission and management have been disseminated. Misinformation and associated public confusion now extend to the COVID-19 vaccines, spanning from claims based on possible links between some vaccine types and rare blood clots, to baseless claims. As a result, the public’s trust in COVID-19 vaccines has been eroded, fuelling an already troubling trend of vaccine hesitancy. As medication experts and the most accessible healthcare providers, pharmacists are well equipped with the required skills and knowledge to improve COVID-19 vaccine uptake by taking roles that range from dispelling myths, to providing reliable evidence-based information, through to vaccine administration. This paper discusses public hesitancy to COVID-19 vaccines, major contributing factors, and the role pharmacists can play in reducing hesitancy and increasing vaccine uptake.
Original languageEnglish
Pages (from-to)494-500
Number of pages7
JournalJournal of Pharmacy Practice and Research
Volume51
Issue number6
DOIs
Publication statusPublished - Dec 2021

Fingerprint

Dive into the research topics of 'Public hesitancy to COVID‐19 vaccine and the role of pharmacists in addressing the problem and improving uptake'. Together they form a unique fingerprint.

Cite this